Stereochemical Aspects of Drug Action and Disposition

[1]  M. Eichelbaum,et al.  Stereoselectivity in cardiovascular and biochemical action of calcium antagonists: Studies with the enantiomers of the dihydropyridine nitrendipine , 1995, Clinical pharmacology and therapeutics.

[2]  R. Nation.  Chirality in New Drug Development , 1994, Clinical pharmacokinetics.

[3]  R. Day,et al.  The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid. , 1994, British journal of clinical pharmacology.

[4]  A. Burm,et al.  Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. , 1994, British journal of clinical pharmacology.

[5]  C. Alm,et al.  Stereoselective disposition of mianserin is related to debrisoquin hydroxylation polymorphism , 1994, Clinical pharmacology and therapeutics.

[6]  K. Higaki,et al.  Stereoselective renal tubular secretion of an organic anion in the isolated perfused rat kidney. , 1994, The Journal of pharmacology and experimental therapeutics.

[7]  J. Schwartz,et al.  Aging of women alters S‐verapamil pharmacokinetics and pharmacodynamics , 1994, Clinical pharmacology and therapeutics.

[8]  M. Fromm,et al.  An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy. , 1994, Circulation.

[9]  B. Leyland-Jones,et al.  Ifosfamide stereoselective dichloroethylation and neurotoxicity , 1994, The Lancet.

[10]  F. Jamali,et al.  Etodolac Clinical Pharmacokinetics , 1994, Clinical pharmacokinetics.

[11]  J. Lötsch,et al.  Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. , 1994, British journal of clinical pharmacology.

[12]  H. Chrystyn,et al.  Enantiomeric separation of R- and S-ifosfamide and their determination in serum from clinical subjects. , 1994, Journal of chromatography. B, Biomedical applications.

[13]  M. Gnant,et al.  Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancer. , 1994, British journal of clinical pharmacology.

[14]  A. Somogyi,et al.  Interaction of the stereoisomers of basic drugs with the uptake of tetraethylammonium by rat renal brush-border membrane vesicles. , 1994, Journal of Pharmacology and Experimental Therapeutics.

[15]  S. Hall,et al.  The role of coenzyme A in the biotransformation of 2-arylpropionic acids. , 1994, Chemico-biological interactions.

[16]  S. Kitareewan,et al.  Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. , 1994, Biochemistry.

[17]  C. Prakash,et al.  Stereoselective disposition of hexobarbital and its metabolites: relationship to the S-mephenytoin polymorphism in Caucasian and Chinese subjects. , 1994, Pharmacogenetics.

[18]  S. Fukushima,et al.  Inhibitory effects of procainamide and probenecid on renal excretion of sultopride enantiomers in rats. , 1993, Journal of pharmaceutical sciences.

[19]  Y. Masubuchi,et al.  Substrate stereoselectivity and enantiomer/enantiomer interaction in propranolol metabolism in rat liver microsomes. , 1993, Biochemical pharmacology.

[20]  F. Jamali,et al.  Stereoselective Dissolution of Propranolol Hydrochloride from Hydroxypropyl Methylcellulose Matrices , 1993, Pharmaceutical Research.

[21]  R. Yates,et al.  Metabolism and enantioselective pharmacokinetics of Casodex in man. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.

[22]  R. Farinotti,et al.  Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[23]  G. Granneman,et al.  Stereoselective pharmacokinetics of pazinaclone, a new non-benzodiazepine anxiolytic, and its active metabolite in healthy subjects. , 1993, British journal of clinical pharmacology.

[24]  P. Langguth,et al.  The pharmacokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and the single enantiomers. , 1993, British journal of clinical pharmacology.

[25]  J. Cody,et al.  Interpretation of methamphetamine and amphetamine enantiomer data. , 1993, Journal of analytical toxicology.

[26]  M. Eichelbaum,et al.  Identification of P450 enzymes involved in metabolism of verapamil in humans , 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

[27]  A. Ebihara,et al.  The effects of age and gender on the stereoselective pharmacokinetics of verapamil , 1993, Clinical pharmacology and therapeutics.

[28]  H. Thijssen,et al.  Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics , 1993, British journal of pharmacology.

[29]  J. Turgeon,et al.  Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humans. , 1993, The Journal of pharmacology and experimental therapeutics.

[30]  D. Abernethy,et al.  Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration. , 1993, The Journal of pharmacology and experimental therapeutics.

[31]  J. Turgeon,et al.  Stereoselective disposition of (+/-)-sotalol at steady-state conditions. , 1993, British journal of clinical pharmacology.

[32]  R. Day,et al.  Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate. , 1993, British journal of clinical pharmacology.

[33]  J. Orgiazzi,et al.  Purified D-thyroxine in athyreotic patients , 1993, The Lancet.

[34]  G. Geisslinger,et al.  Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis. , 1993, British journal of clinical pharmacology.

[35]  G. Geisslinger,et al.  Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. , 1993, British journal of anaesthesia.

[36]  J. Karbwang,et al.  The pharmacokinetics of quinine in patients with hepatitis. , 1993, British journal of clinical pharmacology.

[37]  P. Augustijns,et al.  Stereoselective Pharmacokinetic Properties of Chloroquine and De-Ethyl-Chloroquine in Humans , 1993, Clinical pharmacokinetics.

[38]  N. White,et al.  A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. , 1993, British journal of clinical pharmacology.

[39]  M. Wright,et al.  Methods for the analysis of enantiomers of racemic drugs application to pharmacological and pharmacokinetic studies. , 1993, Journal of pharmacological and toxicological methods.

[40]  C. Libersa,et al.  Stereoselective Hydroxylation of Mexiletine in Human Liver Microsomes: Implication of P450IID6− A Preliminary Report , 1993, Journal of cardiovascular pharmacology.

[41]  T. Andersson,et al.  A study of the interaction of omeprazole and warfarin in anticoagulated patients. , 1992, British journal of clinical pharmacology.

[42]  F. Jamali,et al.  The Stereoselective Pharmacokinetics of Etodolac in Young and Elderly Subjects, and After Cholecystectomy , 1992, Journal of clinical pharmacology.

[43]  G. Geisslinger,et al.  Pure Enantiomers of 2‐Arylpropionic Acids: Tools in Pain Research and Improved Drugs in Rheumatology , 1992, Journal of clinical pharmacology.

[44]  J. Caldwell.  The importance of stereochemistry in drug action and disposition. , 1992, Journal of clinical pharmacology.

[45]  D. Eyles,et al.  Stereospecific reduction of haloperidol in human tissues. , 1992, Biochemical pharmacology.

[46]  K. Higaki,et al.  Stereoselective pharmacokinetics of a novel uricosuric antihypertensive diuretic in rats: pharmacokinetic interaction between enantiomers. , 1992, Journal of pharmaceutical sciences.

[47]  P. Skolnick,et al.  Isoflurane anesthesia is stereoselective. , 1992, European journal of pharmacology.

[48]  M. Gibaldi,et al.  Mechanisms of the stereoselective interaction between miconazole and racemic warfarin in human subjects , 1992, Clinical pharmacology and therapeutics.

[49]  J. Gerber,et al.  Age and gender influence the stereoselective pharmacokinetics of propranolol. , 1992, The Journal of pharmacology and experimental therapeutics.

[50]  G. Noseda,et al.  The dispositional enantioselectivity of indobufen in man. , 1992, Biochemical pharmacology.

[51]  P. McNamara,et al.  Age and propranolol stereoselective disposition in humans , 1992, Clinical pharmacology and therapeutics.

[52]  J. Le bras,et al.  In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. , 1992, British journal of clinical pharmacology.

[53]  S. Hall,et al.  Stereoselective disposition of flurbiprofen in normal volunteers. , 1992, British journal of clinical pharmacology.

[54]  H. Hakusui,et al.  Species-related stereoselective disposition of ofloxacin in the rat, dog and monkey. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[55]  B. Obermayer-Pietsch,et al.  Racemic (R,S)‐propranolol versus half‐dosed optically pure (S)‐propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels , 1992, Clinical pharmacology and therapeutics.

[56]  M. Gibaldi,et al.  The mechanism of the interaction between amiodarone and warfarin in humans , 1992, Clinical pharmacology and therapeutics.

[57]  M. Eichelbaum,et al.  Predictability of the in vivo metabolism of verapamil from in vitro data: contribution of individual metabolic pathways and stereoselective aspects. , 1992, The Journal of pharmacology and experimental therapeutics.

[58]  K. Midha,et al.  Extensive and enantioselective presystemic metabolism of dl-threo-methylphenidate in humans , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[59]  D. Smith,et al.  Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin. , 1991, British journal of clinical pharmacology.

[60]  H. Hakusui,et al.  Enantioselective disposition of ofloxacin in humans , 1991, Antimicrobial Agents and Chemotherapy.

[61]  I. Niopas,et al.  Further insight into the stereoselective interaction between warfarin and cimetidine in man. , 1991, British journal of clinical pharmacology.

[62]  H. Ogata,et al.  Comparative pharmacokinetics of unbound disopyramide enantiomers following oral administration of racemic disopyramide in humans. , 1991, Journal of pharmaceutical sciences.

[63]  M. Eichelbaum,et al.  Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism. , 1991, Molecular pharmacology.

[64]  D. Roden,et al.  Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers , 1991, Clinical pharmacology and therapeutics.

[65]  R. Mehvar.  Apparent stereoselectivity in propafenone uptake by human and rat erythrocytes , 1991, Biopharmaceutics & drug disposition.

[66]  T. Vree,et al.  Direct high pressure liquid chromatographic analysis and preliminary pharmacokinetics of enantiomers of oxazepam and temazepam with their corresponding glucuronide conjugates , 1991, Pharmaceutisch Weekblad.

[67]  F. Jamali,et al.  Pharmacokinetics of acebutolol enantiomers in humans. , 1991, Journal of pharmaceutical sciences.

[68]  J. Clapham,et al.  Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models. , 1991, Arzneimittel-Forschung.

[69]  B. Peskar,et al.  Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition , 1991, Experientia.

[70]  T. Miller,et al.  Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration. , 1991, Journal of the National Cancer Institute.

[71]  W. Hooper,et al.  The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans , 1990, Clinical pharmacology and therapeutics.

[72]  L. Aarons,et al.  Investigations into the potential effects of multiple dose ketorolac on the pharmacokinetics and pharmacodynamics of racemic warfarin. , 1990, British journal of clinical pharmacology.

[73]  W. L. Nelson,et al.  Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprolol. , 1990, Biochemical pharmacology.

[74]  G. Tucker,et al.  Plasma concentrations of the stereoisomers of prilocaine after administration of the racemate: implications for toxicity? , 1990, British journal of anaesthesia.

[75]  D. Breimer,et al.  Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects. , 1990, British journal of clinical pharmacology.

[76]  M. Fujimaki,et al.  Assay and disposition of carvedilol enantiomers in humans and monkeys: evidence of stereoselective presystemic metabolism. , 1990, Journal of pharmaceutical sciences.

[77]  U. Klotz,et al.  Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action. , 1990, The Journal of pharmacology and experimental therapeutics.

[78]  K. Stoschitzky,et al.  Different stereoselective effects of (R)‐ and (S)‐propafenone: Clinical pharmacologic, electrophysiologic, and radioligand binding studies , 1990, Clinical pharmacology and therapeutics.

[79]  A. Wood,et al.  Differences in stereoselective disposition of propranolol do not explain sensitivity differences between white and Chinese subjects: Correlation between the clearance of (−)‐ and (+)‐propranolol , 1990, Clinical pharmacology and therapeutics.

[80]  M. Bottorff,et al.  Effects of age on the protein binding and disposition of propranolol stereoisomers , 1990, Clinical pharmacology and therapeutics.

[81]  W. Lindner,et al.  THE EFFECT OF D‐ VERSUS L‐ PROPRANOLOL IN THE TREATMENT OF HYPERTHYROIDISM , 1990, Clinical endocrinology.

[82]  S. Kaye,et al.  The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific. , 1990, Biochemical pharmacology.

[83]  H. Boudoulas,et al.  Antiarrhythmic Activity and Unbound Concentrations of Disopyramide Enantiomers in Patients , 1990, Therapeutic drug monitoring.

[84]  A. S. Gross,et al.  Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype. , 1989, British journal of clinical pharmacology.

[85]  P. Höglund,et al.  No Effect of Terodiline on Anticoagulation Effect of Warfarin and Steady‐State Plasma Levels of Warfarin Enantiomers in Healthy Volunteers , 1989, Therapeutic drug monitoring.

[86]  T. Walle,et al.  A stereoselective central hypotensive action of atenolol. , 1989, The Journal of pharmacology and experimental therapeutics.

[87]  A. Hertog,et al.  The action of flecainide acetate and its enantiomers on mammalian non-myelinated nerve fibres , 1989, Pharmaceutisch Weekblad.

[88]  L. Bertilsson,et al.  Stereoselective disposition of racemic E‐10‐hydroxynortriptyline in human beings , 1989, Clinical pharmacology and therapeutics.

[89]  M. S. Langley,et al.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. , 1989, Drugs.

[90]  S. Hall,et al.  Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status. , 1989, The Journal of pharmacology and experimental therapeutics.

[91]  D. Roden,et al.  Stereoselective disposition and pharmacologic activity of propafenone enantiomers. , 1989, Circulation.

[92]  J. Lima,et al.  Hemodynamic and electrophysiologic effects of disopyramide enantiomers in a canine blood superfusion model. , 1989, Journal of cardiovascular pharmacology.

[93]  G R Wilkinson,et al.  Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. , 1989, The New England journal of medicine.

[94]  P. Höglund,et al.  Stereoselective Interaction of Omeprazole with Warfarin in Healthy Men , 1989, Therapeutic drug monitoring.

[95]  W. Hooper,et al.  Stereoselective metabolism and pharmacokinetics of racemic methylphenobarbital in humans. , 1989, Drug metabolism and disposition: the biological fate of chemicals.

[96]  M. Eichelbaum,et al.  Stereoselective protein binding of verapamil enantiomers. , 1988, Biochemical pharmacology.

[97]  L. Sansom,et al.  Stereoselective drug disposition: potential for misinterpretation of drug disposition data. , 1988, British journal of clinical pharmacology.

[98]  R. Le Verge,et al.  Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[99]  M. Eichelbaum,et al.  Electrophysiologic Effects of Dextro‐ and Levo‐Verapamil on Sinus Node and AV Node Function in Humans , 1988, Journal of cardiovascular pharmacology.

[100]  H. Duff,et al.  Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels. , 1988, Molecular pharmacology.

[101]  M. Hollmann,et al.  Comparative pharmacokinetics and clinical pharmacology of propafenone enantiomers after oral administration to man. , 1988, Methods and findings in experimental and clinical pharmacology.

[102]  E. Lunell,et al.  No effect of roxithromycin on pharmacokinetic or pharmacodynamic properties of warfarin and its enantiomers. , 1988, Pharmacology & toxicology.

[103]  P. Meffin,et al.  Enantiospecific formation of fenoprofen coenzyme A thioester in vitro. , 1988, Biochemical Pharmacology.

[104]  A. Russell,et al.  Stereoselective pharmacokinetics of flurbiprofen in humans and rats. , 1988, Journal of pharmaceutical sciences.

[105]  Y. W. Lam,et al.  Stereoselectivity: An Issue of Significant Importance in Clinical Pharmacology , 1988, Pharmacotherapy.

[106]  M. Rowland,et al.  Stereospecific assay of nicoumalone: application to pharmacokinetic studies in man. , 1988, British journal of clinical pharmacology.

[107]  U. Quast,et al.  Mechanism of Action and Systemic and Regional Hemodynamics of the Potassium Channel Activator BRL34915 and Its Enantiomers , 1988, Circulation research.

[108]  R. Blouin,et al.  Age‐associated stereoselective alterations in hexobarbital metabolism , 1988, Clinical pharmacology and therapeutics.

[109]  J. Nathanson.  Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary process. , 1988, The Journal of pharmacology and experimental therapeutics.

[110]  L. Bertilsson,et al.  Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine. , 1988, British journal of clinical pharmacology.

[111]  S. Toon,et al.  The racemic metoprolol H2‐antagonist interaction , 1988, Clinical pharmacology and therapeutics.

[112]  C. Peterson,et al.  D‐verapamil and L‐verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro , 1988, International journal of cancer.

[113]  E. Smith,et al.  Stereoselectivity of tocainide pharmacodynamics in vivo and in vitro. , 1988, Journal of cardiovascular pharmacology.

[114]  A. Uprichard,et al.  Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation. , 1988, Journal of cardiovascular pharmacology.

[115]  M. S. Ching,et al.  Differences in the binding of quinine and quinidine to plasma proteins. , 1987, British journal of clinical pharmacology.

[116]  G. Fromm,et al.  Comparison of L‐baclofen and racernic baclofen in trigeminal neuralgia , 1987, Neurology.

[117]  M. Gibaldi,et al.  The mechanism of the warfarin‐rifampin drug interaction in humans , 1987, Clinical pharmacology and therapeutics.

[118]  A. Tattersfield,et al.  Comparison of the airway response to eye drops of timolol and its isomer L-714,465 in asthmatic subjects. , 1987, British journal of clinical pharmacology.

[119]  W. Trager,et al.  Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans , 1987, Clinical pharmacology and therapeutics.

[120]  L. Aarons,et al.  Enoxacin‐warfarin interaction: Pharmacokinetic and stereochemical aspects , 1987, Clinical pharmacology and therapeutics.

[121]  D. Drayer,et al.  Pharmacokinetics of pentobarbital enantiomers as determined by enantioselective radioimmunoassay after administration of racemate to humans and rabbits. , 1987, The Journal of pharmacology and experimental therapeutics.

[122]  G. Breese,et al.  Pharmacology of the enantiomers of threo-methylphenidate. , 1987, The Journal of pharmacology and experimental therapeutics.

[123]  Ö. Ericsson,et al.  Enantioselective Analysis of Chloroquine and Desethylchloroquine after Oral Administration of Racemic Chloroquine , 1986, Therapeutic drug monitoring.

[124]  A. Breckenridge,et al.  Enantiomers of warfarin and vitamin K1 metabolism. , 1986, British journal of clinical pharmacology.

[125]  M. Alkondon,et al.  Nonstereoselective aspects of propranolol pharmacodynamics. , 1986, Canadian journal of physiology and pharmacology.

[126]  J. Kuritsky,et al.  Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. , 1986, American journal of ophthalmology.

[127]  D. Notterman,et al.  Stereoselective renal tubular secretion of quinidine and quinine , 1986, Clinical pharmacology and therapeutics.

[128]  P. Schechter,et al.  Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S‐enantiomer , 1986, Clinical pharmacology and therapeutics.

[129]  K. Williams,et al.  The stereoselective uptake of ibuprofen enantiomers into adipose tissue. , 1986, Biochemical pharmacology.

[130]  F. Sjöqvist,et al.  Protein binding of chloroquine enantiomers and desethylchloroquine. , 1986, British journal of clinical pharmacology.

[131]  M. Curtis,et al.  The mechanism of action of the optical enantiomers of verapamil against ischaemia‐induced arrhythmias in the conscious rat , 1986, British journal of pharmacology.

[132]  W. L. Nelson,et al.  In vivo interaction of the enantiomers of disopyramide in human subjects , 1986, Journal of Pharmacokinetics and Biopharmaceutics.

[133]  D. Greenblatt,et al.  Pharmacokinetics and dynamics of penbutolol in humans: Evidence for pathway-specific stereoselective clearance , 1986, Klinische Wochenschrift.

[134]  Z. Tang,et al.  Pharmacokinetics of (±)‐, (+)‐, and (−)‐gossypol in humans and dogs , 1986, Clinical pharmacology and therapeutics.

[135]  A. Breckenridge,et al.  Stereoselective interaction between the R enantiomer of warfarin and cimetidine. , 1986, British journal of clinical pharmacology.

[136]  J. R. Schmid,et al.  Resolution of flecainide acetate, N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzam ide acetate, and antiarrhythmic properties of the enantiomers. , 1986, Journal of medicinal chemistry.

[137]  B. Diquet,et al.  The warfarin-cimetidine interaction: stereochemical considerations. , 1986, British journal of clinical pharmacology.

[138]  C. Leier,et al.  Cardiovascular effects of ophthalmic timolol. , 1986, Annals of internal medicine.

[139]  M. Gibaldi,et al.  The warfarin‐sulfinpyrazone interaction: stereochemical considerations , 1986, Clinical pharmacology and therapeutics.

[140]  R. Ruffolo,et al.  Effects of dopamine, (+/-)-dobutamine and the (+)- and (-)-enantiomers of dobutamine on cardiac function in pithed rats. , 1985, The Journal of pharmacology and experimental therapeutics.

[141]  S. Bjorkman.  Stereoselective disposition of indoprofen in surgical patients. , 1985 .

[142]  K. Giacomini,et al.  Stereoselective renal clearance of pindolol in humans. , 1985, The Journal of clinical investigation.

[143]  R. Branch,et al.  Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation , 1985, Clinical pharmacology and therapeutics.

[144]  H. Boudoulas,et al.  Stereoselective pharmacokinetics of disopyramide enantiomers in man. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[145]  R. Branch,et al.  Phenotypic differences in mephenytoin pharmacokinetics in normal subjects. , 1985, The Journal of pharmacology and experimental therapeutics.

[146]  M. Bechem,et al.  The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels. , 1985, European journal of pharmacology.

[147]  U. Ruegg,et al.  Stereoselectivity at the Calcium Channel: Opposite Action of the Enantiomers of a 1,4‐Dihydropyridine , 1985, Journal of cardiovascular pharmacology.

[148]  M. Eichelbaum,et al.  Effects of d,l‐verapamil on atrioventricular conduction in relation to its stereoselective first‐pass metabolism , 1985, Clinical pharmacology and therapeutics.

[149]  H. Glossmann,et al.  Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart , 1985, British journal of pharmacology.

[150]  K. Netter.  Progress in drug metabolism , 1985 .

[151]  M. Eichelbaum,et al.  The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans. , 1985, American heart journal.

[152]  J Schüttler,et al.  Comparative pharmacology of the ketamine isomers. Studies in volunteers. , 1985, British journal of anaesthesia.

[153]  C. Gorman,et al.  L‐Thyroxine contamination of pharmaceutical D‐thyroxine: Probable cause of therapeutic effect , 1984, Clinical pharmacology and therapeutics.

[154]  M. Eichelbaum,et al.  Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. , 1984, British journal of clinical pharmacology.

[155]  T. Walle,et al.  Stereoselective ring oxidation of propranolol in man. , 1984, British journal of clinical pharmacology.

[156]  M. Contin,et al.  Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma. , 1984, British journal of clinical pharmacology.

[157]  M. Simonyi.  On chiral drug action , 1984, Medicinal research reviews.

[158]  R. Branch,et al.  Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans. , 1984, The Journal of pharmacology and experimental therapeutics.

[159]  R. Stone,et al.  The effect of d-timolol on intraocular pressure in patients with ocular hypertension. , 1984, American journal of ophthalmology.

[160]  G. Wilkinson,et al.  Polymorphic ability to metabolize propranolol alters 4‐hydroxypropranolol levels but not beta blockade , 1984, Clinical pharmacology and therapeutics.

[161]  G. Tucker,et al.  The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol. , 1984, British journal of clinical pharmacology.

[162]  T. Walle,et al.  Stereoselective clearance and distribution of intravenous propranolol , 1984, Clinical pharmacology and therapeutics.

[163]  G. Tucker,et al.  Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers , 1983, Clinical pharmacology and therapeutics.

[164]  E. Chan,et al.  Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations. , 1983, British journal of clinical pharmacology.

[165]  J. Caldwell,et al.  The metabolic chiral inversion of 2‐arylpropionic acids—a novel route with pharmacological consequences , 1983, The Journal of pharmacy and pharmacology.

[166]  P. Timmermans.  Stereochemistry and Biological Activity of Drugs , 1983 .

[167]  R. Pinder,et al.  The potential therapeutic role of the enantiomers and metabolites of mianserin. , 1983, British journal of clinical pharmacology.

[168]  G. P. Levy,et al.  THE α‐ AND β‐ADRENOCEPTOR BLOCKING POTENCIES OF LABETALOL AND ITS INDIVIDUAL STEREOISOMERS IN ANAESTHETIZED DOGS AND IN ISOLATED TISSUES , 1982 .

[169]  R. O'Reilly.  Ticrynafen‐racemic warfarin interaction: Hepatotoxic or stereoselective? , 1982, Clinical pharmacology and therapeutics.

[170]  J. Hermansson,et al.  Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man. , 1982, British journal of clinical pharmacology.

[171]  N. Holford,et al.  Stereoselective disposition and glucuronidation of propranolol in humans. , 1982, Journal of pharmaceutical sciences.

[172]  R. O'Reilly.  Stereoselective Interaction of Sulfinpyrazone with Racemic Warfarin and Its Separated Enantiomorphs in Man , 1982, Circulation.

[173]  S. Nelson,et al.  Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol. , 1981, The Journal of pharmacology and experimental therapeutics.

[174]  R. Branch,et al.  Stereoselective metabolism of mephenytoin in man. , 1981, The Journal of pharmacology and experimental therapeutics.

[175]  T. Tsuruo,et al.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. , 1981, Cancer research.

[176]  E. Sellers,et al.  Methadone binding to orosomucoid (α1‐acid glycoprotein): Determinant of free fraction in plasma , 1981 .

[177]  S. Riegelman,et al.  Stereospecific assay for (-)- and (+)-propranolol in human and dog plasma. , 1980, The Journal of pharmacology and experimental therapeutics.

[178]  K. Giacomini,et al.  Comparative anticholinergic potencies of R- and S- disopyramide in longitudinal muscle strips from guinea pig ileum. , 1980, Life sciences.

[179]  M. Eichelbaum,et al.  Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single i.v. and oral administration and during chronic treatment , 1980, Klinische Wochenschrift.

[180]  W. Trager,et al.  Interaction of secobarbital with warfarin pseudoracemates , 1980, Clinical pharmacology and therapeutics.

[181]  R. Larkins,et al.  D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine. , 1980, British medical journal.

[182]  T. Yanagisawa,et al.  Coronary Vasodilator and Cardiac Effects of Optical Isomers of Verapamil in the Dog , 1980, Journal of cardiovascular pharmacology.

[183]  P. White,et al.  Pharmacology of Ketamine Isomers in Surgical Patients , 1980, Anesthesiology.

[184]  W. Trager,et al.  Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man. , 1980, The Journal of clinical investigation.

[185]  G. Cheymol,et al.  Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs. , 1980, The Journal of pharmacology and experimental therapeutics.

[186]  R. O'Reilly.  Stereoselective interaction of trimethoprim-sulfamethoxazole with the separated enantiomorphs of racemic warfarin in man. , 1980, The New England journal of medicine.

[187]  E. R. Shepard,et al.  Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans. , 1979, Drug metabolism and disposition: the biological fate of chemicals.

[188]  M. Eichelbaum,et al.  Defective N-oxidation of sparteine in man: A new pharmacogenetic defect , 1979, European Journal of Clinical Pharmacology.

[189]  H. Haas,et al.  The biological activity of d-baclofen (Lipresal®) , 1978 .

[190]  F. Reynolds,et al.  An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine. , 1978, British journal of clinical pharmacology.

[191]  J. Idle,et al.  POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN , 1977, The Lancet.

[192]  N. Gerber,et al.  Clinical eftects and pharmacokinetics of racemic methadone and its optical isomers , 1977, Clinical pharmacology and therapeutics.

[193]  P. Murphy,et al.  Effect of l-propoxyphene on plasma levels and analgesic activity of d-propoxyphene in the rat. , 1976, The Journal of pharmacology and experimental therapeutics.

[194]  T. Meinertz,et al.  The enantiomers of phenprocoumon: Pharmacodynamic and pharmacokinetic studies , 1976, Clinical pharmacology and therapeutics.

[195]  R. O'Reilly.  The stereoselective interaction of warfarin and metronidazole in man. , 1976, The New England journal of medicine.

[196]  W. Wechter,et al.  Isomeric inversion of ibuprofen (R)-enantiomer in humans. , 1976, Journal of pharmaceutical sciences.

[197]  D. Miller,et al.  Molecular geometry and adrenergic drug activity. , 1974, Pharmacological reviews.

[198]  A. Breckenridge,et al.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. , 1974, The Journal of clinical investigation.

[199]  J. Morris,et al.  Active Transport of L-Dopa in the Intestine , 1973, Nature.

[200]  J. Stamler.  The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group. , 1972, JAMA.

[201]  D. Shand,et al.  Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in Man , 1970, British medical journal.

[202]  George C. Cotzias,et al.  Modification of Parkinsonism--chronic treatment with L-dopa. , 1969, The New England journal of medicine.

[203]  A. Barrett,et al.  The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias , 1968, British journal of pharmacology.

[204]  L. Schiffer,et al.  Aromatic amino acids and modification of parkinsonism. , 1967, The New England journal of medicine.

[205]  A. M. Lands,et al.  $$Word$$ PHARMACOLOGIC ACTIVITY OF THE OPTICAL ISOMERS OF ISOPROPYLARTERENOL (ISUPREL) COMPARED WITH THAT OF THE OPTICALLY INACTIVE ANALOG 1-(3,4-DIHYDROXY PHENYL)-2-ISOPROPYLAMINOETHANE HCl , 1954 .

[206]  K. Strein,et al.  Pharmacological characteristics of the stereoisomers of carvedilol , 2005, European Journal of Clinical Pharmacology.

[207]  C. A. Stone,et al.  R-Enantiomer of timolol: a potential selective ocular antihypertensive agent , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[208]  M. Nishikata,et al.  Enantioselective pharmacokinetics of homochlorcyclizine II: disposition and metabolism of (+)-, (−)- and racemic homochlorcyclizine after oral administration to man , 2005, European Journal of Clinical Pharmacology.

[209]  S. Toon,et al.  Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man , 2004, European Journal of Clinical Pharmacology.

[210]  L. Sansom,et al.  Stereoselective plasma protein binding of ibuprofen enantiomers , 2004, European Journal of Clinical Pharmacology.

[211]  H. Brodthagen,et al.  Entero-hepatic cycling of methotrexate estimated by use of the D-isomer as a reference marker , 2004, European Journal of Clinical Pharmacology.

[212]  E. J. Ariëns.  Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology , 2004, European Journal of Clinical Pharmacology.

[213]  H. Schoemaker,et al.  Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics , 2004, European Journal of Clinical Pharmacology.

[214]  A. Evans.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs , 2004, European Journal of Clinical Pharmacology.

[215]  W. Krause,et al.  Pharmacokinetics of (+)-rolipram and (−)-rolipram in healthy volunteers , 2004, European Journal of Clinical Pharmacology.

[216]  M. Eichelbaum,et al.  Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines , 2004, European Journal of Clinical Pharmacology.

[217]  T. Kronbach,et al.  Stereo- and regioselectivity of hepatic oxidation in man — Effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylation , 2004, European Journal of Clinical Pharmacology.

[218]  E. Mutschler,et al.  Single- and multiple-dose pharmacokinetics of R-(−)- and S-(+)-prenylamine in man , 2004, European Journal of Clinical Pharmacology.

[219]  H. Thijssen,et al.  Lack of effect of cimetidine on pharmacodynamics and kinetics of single oral doses of R- and S-acenocoumarol , 2004, European Journal of Clinical Pharmacology.

[220]  R. Nation,et al.  The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate. , 1994, British journal of clinical pharmacology.

[221]  T. Walle,et al.  The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers. , 1994, British journal of clinical pharmacology.

[222]  B. J. Cooke.  Chirality of methamphetamine and amphetamine from workplace urine samples. , 1994, Journal of Analytical Toxicology.

[223]  N. Cutler,et al.  Pharmacodynamics and drug development : perspectives in clinical pharmacology , 1994 .

[224]  M. Eichelbaum,et al.  Enantioselective gallopamil protein binding. , 1993, Chirality.

[225]  E. Chan,et al.  Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone. , 1993, Chirality.

[226]  J. Millership,et al.  Commonly used chiral drugs: a survey. , 1993, Chirality.

[227]  J. Longstreth,et al.  Stereospecific determination of the in vitro dissolution of modified release formulations of (±)-verapamil , 1993 .

[228]  J. Young,et al.  Rac-flurbiprofen is more ulcerogenic than its (S)-enantiomer. , 1993, Chirality.

[229]  K. Stoschitzky,et al.  Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies. , 1993, Chirality.

[230]  H. Zhou,et al.  Lack of effect of ageing on the stereochemical disposition of propranolol. , 1992, British journal of clinical pharmacology.

[231]  M. Eichelbaum,et al.  Use of pseudoracemic nitrendipine to elucidate the metabolic steps responsible for stereoselective disposition of nitrendipine enantiomers. , 1992, British journal of clinical pharmacology.

[232]  R. Le Verge,et al.  Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans. , 1992, Chirality.

[233]  T. Aoyama,et al.  Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. , 1992, Chemical research in toxicology.

[234]  M. Gibaldi,et al.  Metabolic enantiomeric interactions: the inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin. , 1991, Chirality.

[235]  J. Caldwell,et al.  Regulatory aspects of the development of chiral drugs in Japan : a status report , 1991 .

[236]  M. Cayen.  Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug development , 1991 .

[237]  T. Grogan,et al.  P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[238]  K M Williams,et al.  Enantiomers in arthritic disorders. , 1990, Pharmacology & therapeutics.

[239]  G. Tucker,et al.  Enantiomer specific pharmacokinetics. , 1990, Pharmacology & therapeutics.

[240]  W. Hooper,et al.  Enantioselective binding of mephobarbital to plasma proteins. , 1990, Chirality.

[241]  B Testa,et al.  Racemates versus enantiomers in drug development: dogmatism or pragmatism? , 1990, Chirality.

[242]  O. Okazaki,et al.  Stereoselective metabolic disposition of enantiomers of ofloxacin in rats. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[243]  B. Testa.  Mechanisms of chiral recognition in xenobiotic metabolism and drug-receptor interactions. , 1989, Chirality.

[244]  C. Kerr,et al.  The pharmacokinetics of the enantiomers of mexiletine in humans. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[245]  G. Baker,et al.  Implications of chirality and geometric isomerism in some psychoactive drugs and their metabolites. , 1989, Chirality.

[246]  K. Stoschitzky,et al.  Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)- and (R,S)-propranolol. , 1989, Chirality.

[247]  J. Paulson,et al.  Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. , 1989, British journal of clinical pharmacology.

[248]  B. K. Park,et al.  Warfarin: metabolism and mode of action. , 1988, Biochemical pharmacology.

[249]  M. Eichelbaum,et al.  Pharmacokinetic and pharmacodynamic consequences of stereoselective drug metabolism in man. , 1988, Biochemical pharmacology.

[250]  T. Walle,et al.  Stereoselective delivery and actions of beta receptor antagonists. , 1988, Biochemical pharmacology.

[251]  J. Caldwell,et al.  Metabolism of xenobiotics , 1988 .

[252]  E. J. Ariëns,et al.  Stereoselectivity of bioactive xenobiotics. A pre-Pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology. , 1988, Biochemical pharmacology.

[253]  B. Testa.  Substrate and product stereoselectivity in monooxygenase-mediated drug activation and inactivation. , 1988, Biochemical pharmacology.

[254]  J. Caldwell,et al.  The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. , 1988, Biochemical pharmacology.

[255]  J. Bada,et al.  Dietary D-amino acids. , 1987, Annual review of nutrition.

[256]  R. Wolen,et al.  Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans. , 1985, Journal of pharmaceutical sciences.

[257]  J. Sawynok,et al.  D-Baclofen is an antagonist at baclofen receptors mediating antinociception in the spinal cord. , 1985, Pharmacology.

[258]  B. Testa,et al.  The influence of stereochemical factors on drug disposition. , 1973, Drug metabolism reviews.

[259]  L. H. Easson,et al.  Studies on the relationship between chemical constitution and physiological action: Molecular dissymmetry and physiological activity. , 1933, The Biochemical journal.